I think there is so much to learn. But that said, I feel we're in hopeful times. We're understanding more about these tumors so that way we can help us develop better therapies not only to have ...

AbstractBackground:. Intraductal papillary mucinous neoplasms are recognized precursor lesions to pancreatic ductal adenocarcinoma (PDAC). There remains an unmet need to establish biomarkers for ...

The U.S. Food and Drug Administration (FDA) has approved Cabometyx (cabozantinib) for some patients 12 years of age and older with previously treated neuroendocrine tumors. The approval was based on ...

These symptoms can be true regardless of whether a pancreatic head tumor is from an adenocarcinoma or neuroendocrine tumor. For patients whose cancer originates in the tail of the pancreas — on the ...

The U.S. Food & Drug Administration has granted approval for a new drug to treat pancreatic neuroendocrine tumors, also called PNET or PanNET. “I am delighted that patients with pancreatic ...

NET are heterogeneous tumors that arise from the neuroendocrine cells of the digestive tract and other organs, such as the lung and pancreas. Most patients with advanced disease face a poor ...

Neuroendocrine tumors (NETs) can begin almost anywhere in the body. They start from cells that make and release hormones. Many physicians never see a patient with this rare type of cancer. But at Fred ...

NET are cancers that begin in the specialized cells of the body’s neuroendocrine system. 1 These cells have traits of both hormone-producing endocrine cells and nerve cells. 1 In 2024, the ...

Pancreatic neuroendocrine tumor: Cancer of the endocrine cells. Treatment for pancreatic cancer involves surgery to remove part or all of the pancreas in addition to radiation and chemotherapy. Some ...

MUSC Hollings Cancer Center launches next-day appointment access for patients diagnosed with abdominal cancer.The new program is built for patients diagnosed w ...